Developing a two‐sided intervention to facilitate shared decision‐making in haemophilia: decision boxes for clinicians and patient decision aids for patients
- 2 October 2014
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 20 (6) , 800-806
Abstract
Background: People with haemophilia face many treatment decisions, which are largely informed by evidence from observational studies. Without evidence‐based ‘best’ treatment options, patient preferences play a large role in decisions regarding therapy. The shared decision‐making (SDM) process allows patients and health care providers to make decisions collaboratively based on available evidence, and patient preferences. Decision tools can help the SDM process. The objective of this project was to develop two‐sided decision tools, decision boxes for physicians and patient decision aids for patients, to facilitate SDM for treatment decisions in haemophilia. Methods. Development of the decision tools comprised three phases: topic selection, prototype development and usability testing with targeted end‐users. Topics were selected using a Delphi survey. Tool prototypes were based on a previously validated framework and were informed by systematic literature reviews. Patients, through focus groups, and physicians, through interviews, reviewed the prototypes iteratively for comprehensibility and usability. Results. The chosen topics were: (i) prophylactic treatment: when to start and dosing, (ii) choosing factor source and (iii) immunotolerance induction: when to start and dosing. Intended end users (both health care providers and haemophilia patients and caregivers) were engaged in the development process. Overall perception of the decision tools was positive, and the purpose of using the tools was well received. Conclusions. This study demonstrates the feasibility of developing decision tools for haemophilia treatment decisions. It also provides anecdotal evidence of positive perceptions of such tools. Future directions include assessment of the tools’ practical value and impact on clinical practice.Keywords
Funding Information
- Biogen Idec
- Mitacs
This publication has 22 references indexed in Scilit:
- Decision boxes for clinicians to support evidence-based practice and shared decision making: the user experienceImplementation Science, 2012
- Concentrate‐related inhibitor risk: is a difference always real?Journal of Thrombosis and Haemostasis, 2011
- Developing and user-testing Decision boxes to facilitate shared decision making in primary care - a study protocolBMC Medical Informatics and Decision Making, 2011
- Harmonization of clinical trial guidelines for assessing the risk of inhibitor development in hemophilia A treatmentJournal of Thrombosis and Haemostasis, 2010
- Treatment of hemophilia: a review of current advances and ongoing issuesJournal of Blood Medicine, 2010
- Clinical trials and haemophilia: does the Bayesian approach make the ideal and desirable good friends?Haemophilia, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Developing a quality criteria framework for patient decision aids: online international Delphi consensus processBMJ, 2006
- An Assessment of the Shared-Decision Model in Parents of Children With Acute Otitis MediaPediatrics, 2005
- Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluationsPatient Education and Counseling, 2005